Clinical Trial

Investigation of REcurrence Mechanisms to Adjuvant osimertINib in Radically Resected EGFR-mutated NSCLC Patients

Name: Investigation of REcurrence Mechanisms to Adjuvant osimertINib in Radically Resected EGFR-mutated NSCLC Patients — clinical trial record (NCT07363252)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: REMAIN

Recruiting

View on ClinicalTrials.gov →

Summary

Retrospective-prospective observational multicentric study including radically resected EGFR-mutated NSCLC patients relapsed during or after adjuvant osimertinib, received according to clinical practice

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-23

Trial Details

NCT Number	NCT07363252
Lead Sponsor	Gruppo Oncologico Italiano di Ricerca Clinica
Conditions	EGFR-mutated NSCLC
Enrollment	100 participants
Start Date	2026-04-14
Primary Completion	2028-12 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-22